Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions

Oxygen depleted hypoxic regions in the tumour are generally resistant to therapies1. Although nanocarriers have been used to deliver drugs, the targeting ratios have been very low. Here, we show that the magneto-aerotactic migration behaviour2 of magnetotactic bacteria3, Magnetococcus marinus strain MC-14, can be used to transport drug-loaded nanoliposomes into hypoxic regions of the tumour. In their natural environment, MC-1 cells, each containing a chain of magnetic iron-oxide nanocrystals5, tend to swim along local magnetic field lines and towards low oxygen concentrations6 based on a two-state aerotactic sensing system2. We show that when MC-1 cells bearing covalently bound drug-containing nanoliposomes were injected near the tumour in SCID Beige mice and magnetically guided, up to 55% of MC-1 cells penetrated into hypoxic regions of HCT116 colorectal xenografts. Approximately 70 drug-loaded nanoliposomes were attached to each MC-1 cell. Our results suggest that harnessing swarms of microorganisms exhibiting magneto-aerotactic behaviour can significantly improve the therapeutic index of various nanocarriers in tumour hypoxic regions.

[1]  R. Blakemore,et al.  Magnetotactic bacteria , 1975, Science.

[2]  Holger W. Jannasch,et al.  Anaerobic magnetite production by a marine, magnetotactic bacterium , 1988, Nature.

[3]  R. Frankel,et al.  Magneto-aerotaxis in marine coccoid bacteria. , 1997, Biophysical journal.

[4]  D. Schüler,et al.  Formation of magnetosomes in magnetotactic bacteria. , 1999, Journal of molecular microbiology and biotechnology.

[5]  R. Jain,et al.  Can engineered bacteria help control cancer? , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. McDonald,et al.  Significance of blood vessel leakiness in cancer. , 2002, Cancer research.

[7]  Louis B Harrison,et al.  Impact of tumor hypoxia and anemia on radiation therapy outcomes. , 2002, The oncologist.

[8]  Ian F Tannock,et al.  Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[10]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[11]  Norval J. C. Strachan,et al.  Modelling magnetic carrier particle targeting in the tumor microvasculature for cancer treatment , 2005 .

[12]  Marcus L. Roper,et al.  Microscopic artificial swimmers , 2005, Nature.

[13]  S. Martel,et al.  Automatic navigation of an untethered device in the artery of a living animal using a conventional clinical magnetic resonance imaging system , 2007 .

[14]  Jennifer Sturgis,et al.  Bacteria-mediated delivery of nanoparticles and cargo into cells. , 2007, Nature nanotechnology.

[15]  Mark W. Dewhirst,et al.  Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment , 2007, Cancer and Metastasis Reviews.

[16]  P. Vaupel,et al.  Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.

[17]  A. Prakash,et al.  Bacteria in cancer therapy: a novel experimental strategy , 2010, Journal of Biomedical Science.

[18]  Gary Friedman,et al.  Magnetic targeting for site-specific drug delivery: applications and clinical potential. , 2009, Expert opinion on drug delivery.

[19]  Y. Pei,et al.  Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Christian A. Ross,et al.  Complete Genome Sequence of the Chemolithoautotrophic Marine Magnetotactic Coccus Strain MC-1 , 2009, Applied and Environmental Microbiology.

[21]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[22]  W. Wilson,et al.  Targeting hypoxia in cancer therapy , 2011, Nature Reviews Cancer.

[23]  T. Williams,et al.  Magnetococcus marinus gen. nov., sp. nov., a marine, magnetotactic bacterium that represents a novel lineage (Magnetococcaceae fam. nov., Magnetococcales ord. nov.) at the base of the Alphaproteobacteria. , 2013, International journal of systematic and evolutionary microbiology.

[24]  Sylvain Martel,et al.  Three-dimensional remote aggregation and steering of magnetotactic bacteria microrobots for drug delivery applications , 2014, Int. J. Robotics Res..

[25]  S. Martel,et al.  Covalent binding of nanoliposomes to the surface of magnetotactic bacteria for the synthesis of self-propelled therapeutic agents. , 2014, ACS nano.

[26]  R. Frankel,et al.  Diversity of magneto-aerotactic behaviors and oxygen sensing mechanisms in cultured magnetotactic bacteria. , 2014, Biophysical journal.